Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06562439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06562439 · ClinicalTrials.gov record · last posted 2026-08-25

Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention

Study acronym: SCCCD
StatusWithdrawn
PhaseNot applicable
Started2025-07-01
View on ClinicalTrials.gov ↗
Why the trial stopped
not a clinical trial
from the ClinicalTrials.gov record
Sickle cell disease affects 100,000 people and 2,000 newborns each year; 50% of these children have a developmental deficit (\>2 SD) before the age of 3. Early identification of developmental deficit supports timely intervention, but children with sickle cell disease are grossly underdiagnosed and undertreated. The goal of the proposed study is to determine the incidence and severity of developmental deficit at 9, 18 and 30 months of age among children with sickle cell disease and test a 12-month, home-based caregiver intervention with this disproportionately affected population.

Protocol amendment history 3 changes detected by DataLookout

2026-08-26
Withdrawn before enrolling
2026-08-26
Trial withdrawn: not a clinical trial
2026-08-26
Enrollment reduced: 50 → 0 participants
Trial Details
NCT Number NCT06562439
Lead Sponsor Washington University School of Medicine
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Sickle Cell Disease
Start Date 2025-07-01
Primary Completion 2028-01-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-25